Active Ingredient: DAPTOMYCIN
Proprietary Name: DAPTOMYCIN
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 350MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217415
Product Number: 001
Approval Date: Jan 30, 2023
Applicant Holder Full Name: XELLIA PHARMACEUTICALS APS
Marketing Status:
Prescription
Patent and Exclusivity Information
